NALM-6 Luciferase Reporter Cell Line
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
NALM-6 Luciferase Reporter Cell Line is generated from NALM-6 Cell Line, expressing the luciferase gene. The cells constitutively express luciferase.
Species | Human |
Cat.No | ABC-RC665H |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Lymphocyte-like |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Acute Lymphoblastic Leukemia |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Reporter Stable Cell Line |
Host Cell | NALM-6 |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
The NALM-6 Luciferase Reporter Cell Line is a genetically modified version of the NALM-6 human B-cell leukemia cell line that has been engineered to express the luciferase enzyme. This allows researchers to measure cellular activities, such as gene expression and signal transduction, by detecting the luminescent signal produced when luciferase catalyzes its substrate.
This cell line is primarily used in cancer research and drug development. It enables the study of B-cell leukemia biology, evaluation of gene regulation, and monitoring of cellular responses to treatments. The luciferase reporter system allows for real-time, non-invasive measurement of biological processes, making it a valuable tool for high-throughput screening and functional assays.
Real-Time Monitoring: Enables real-time tracking of cellular processes through luminescence.
High Sensitivity: Provides high sensitivity and specificity in detecting gene expression and cellular responses.
Versatile Applications: Useful in various research areas, including oncology, immunology, and pharmacology.